MEDICAL DEVICE CLINICAL TRIALS

Medical Device News Magazine brings healthcare professionals, researchers, medical device executives, investors, and industry leaders timely coverage of the latest medical device clinical trials, clinical research studies, emerging scientific data, and technological developments shaping the future of medicine and healthcare.

Our coverage follows medical technologies throughout the clinical development process—from early feasibility and first-in-human studies to pivotal clinical trials, long-term follow-up studies, post-market research, and real-world evidence. Readers can stay informed about new devices and technologies being evaluated across a broad range of medical specialties, including cardiovascular care, vascular medicine, orthopedics, surgery, medical imaging, diagnostics, oncology, neurology, digital health, robotic-assisted surgery, and other rapidly evolving areas of healthcare.

Medical Device News Magazine also reports on important clinical trial results and regulatory milestones, including significant study endpoints, patient outcomes, safety and efficacy findings, FDA submissions, approvals and clearances, and other developments that may influence the commercialization and adoption of new medical technologies.

Beyond reporting study results, our coverage examines the broader significance of medical device research. We highlight innovations that have the potential to improve patient outcomes, provide physicians with new treatment options, reduce procedural complexity, advance minimally invasive care, improve diagnostic accuracy, and address unmet clinical needs.

As medical technology continues to advance at an extraordinary pace, clinical evidence has become increasingly important to physicians, healthcare organizations, regulators, manufacturers, investors, and other decision-makers. Understanding the research behind emerging technologies can provide valuable insight into which innovations may ultimately influence clinical practice and reshape standards of care.

With comprehensive reporting, industry perspectives, and coverage of important scientific and regulatory developments, Medical Device News Magazine helps readers understand not only what is happening in medical device clinical research, but also why it matters.

Whether you are a physician evaluating emerging treatment options, a researcher following new clinical evidence, a medical device executive monitoring industry developments, or an investor assessing the next generation of healthcare technologies, Medical Device News Magazine provides the timely information and insights you need to stay informed in an increasingly innovative and rapidly evolving industry.

TCBP Announces Dosing of 6th Patient in ACHIEVE Study in Patients with Acute Myeloid Leukemia

The ACHIEVE Study UK clinical trial is an open-label, phase II study designed to evaluate the efficacy and effectiveness of TCB-008 in patients with AML or MDS/AML, with either refractory or relapsed disease. ACHIEVE is comprised of two cohorts representing separate disease states. The protocol allows for either cohort to be advanced as an independent Phase III Pivotal Trial upon completion of the cohort, presuming the primary efficacy endpoints is met.